Change of dynamic gastrocnemius and soleus muscle length after block of spastic calf muscle in cerebral palsy

American Journal of Physical Medicine and Rehabilitation

Volumn 81, Issue 10, 2002, Pages 760-764

  Bang, Moon Suk ^a,c   Chung, Sun Gun ^a   Kim, Sang Beom ^b   Kim, Sang Jun ^a  

^a Seoul National University Biomedical Research Institute   (South Korea)

^b Dong A University College of Medicine   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

Cerebral Palsy; Dynamic Gastrocnemius Length; Gait Analysis; Soleus

Indexed keywords

BIOLOGICAL ORGANS; DISEASES; PATIENT REHABILITATION;

CEREBRAL PALSY;

MUSCLE;

BOTULINUM TOXIN; BOTULINUM TOXIN A;

ADOLESCENT; ARTICLE; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; DRUG EFFECT; DYNAMICS; FEMALE; GAIT; GASTROCNEMIUS MUSCLE; HEMIPLEGIA; HUMAN; KNEE FUNCTION; MALE; MUSCLE LENGTH; MUSCLE SPASM; SOLEUS MUSCLE; SPASTICITY;

ADOLESCENT; ANKLE; ANTHROPOMETRY; BOTULINUM TOXIN TYPE A; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; FEMALE; GAIT; HUMANS; IMAGING, THREE-DIMENSIONAL; INJECTIONS, INTRAMUSCULAR; KNEE; MALE; MUSCLE SPASTICITY; MUSCLE, SKELETAL; NEUROMUSCULAR AGENTS; RANGE OF MOTION, ARTICULAR; TREATMENT OUTCOME;

EID: 0036787360     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002060-200210000-00007     Document Type: Article

References (17)

1. Bang MS, Han TR, Lim JY: Motor point block by phenol in spastic cerebral palsy. J Korean Acad Rehabil 1997;21: 71-7
2. Boyd RN, Pliatsios V, Starr R, et al: Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsy. Dev Med Child Neurol 2000;42:32-41
3. Morrison JE, Hertzberg DL, Gourley SM, et al: Motor point blocks in children: A technique to relieve spasticity using phenol injections. AORN J 1989;49: 1346-51
4. Kirschner J, Berweck S, Mall V, et al: Botulinum toxin treatment in cerebral palsy: Evidence for a new treatment option. J Neurol 2001;248(suppl 1):28-30
5. Koman LA, Mooney JF, Smith BP, et al: Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: A randomized, double-blind, placebo-controlled trial. BOTOX Study Group. J Pediatr Orthop 2000;20:108-15
6. Sutherland DH, Kaufman KR, Wyatt MP, et al: Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy. Gait Posture 1999;10:1-9
7. Ubhi T, Bhakta BB, Ives HL, et al: Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Arch Dis Child 2000;83:481-7
8. Wissel J, Heinen F, Schenkel A, et al: Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: A randomized, double-blind study of "highdose" versus "low-dose" treatment. Neuropediatrics 1999;30:120-4
9. Wong V: Use of Botulinum toxin injection in 17 children with spastic cerebral palsy. Pediatr Neurol 1998;18:124-31
10. Eames NWA, Baker RJ, Cosgrove AP: Defining gastrocnemius length in ambulant children. Gait Posture 1997;6:9-17
11. Eames NWA, Baker RJ, Hill N, et al: The effect of botulinum toxin A on gastrocnemius length: Magnitude and duration of response. Dev Med Child Neurol 1999;41:226-32
12. Ettema GJC: Gastrocnemius muscle length in relation to knee and ankle joint angles: Verification of a geometric model and some applications. Anat Rec 1997; 247:1-8
13. Davies TW: Resting length of the human soleus muscle. J Anat 1989;162: 169-75
14. Carpenter EB, Seitz DG: Intramuscular alcohol as an aid in management of spastic cerebral palsy. Dev Med Child Neurol 1980;22:497-501
15. Bakheit AMO: Botulinum Toxin Treatment of Muscle Spasticity. Dublin, Blackhall, 2001, pp 128-9
16. O'Byrne JM, Jenkinson A, O'Brien TM: Quantitative analysis and classification of gait patterns in cerebral palsy using a three-dimensional motion analyzer. J Child Neurol 1998;13:101-8
17. Massin M, Allington N: Role of exercise testing in the functional assessment of cerebral palsy children after botulinum A toxin injection. J Pediatr Orthop 1999; 19:362-5